Chemed Corp Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Chemed Corp has an operating margin of 15.1%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 75/100, reflecting efficient cost management and pricing power. This is up from 15.0% the prior year.
Chemed Corp's revenue grew 7.4% year-over-year to $2.4B, a solid pace of expansion. This earns a growth score of 50/100.
Chemed Corp carries a low D/E ratio of 0.49, meaning only $0.49 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.
Chemed Corp's current ratio of 1.38 indicates adequate short-term liquidity, earning a score of 35/100. The company can meet its near-term obligations, though with limited headroom.
Chemed Corp converts 15.1% of revenue into free cash flow ($368.0M). This strong cash generation earns a score of 76/100.
Chemed Corp earns a strong 27.0% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is up from 24.6% the prior year.
Chemed Corp scores 11.83, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.7B) relative to total liabilities ($549.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Chemed Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Chemed Corp generates $1.38 in operating cash flow ($417.5M OCF vs $302.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Chemed Corp earns $205.9 in operating income for every $1 of interest expense ($366.5M vs $1.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
This page shows Chemed Corp (CHE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Chemed Corp generated $2.4B in revenue in fiscal year 2024. This represents an increase of 7.4% from the prior year.
Chemed Corp's EBITDA was $429.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.0% from the prior year.
Chemed Corp generated $368.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 34.6% from the prior year.
Chemed Corp reported $302.0M in net income in fiscal year 2024. This represents an increase of 10.8% from the prior year.
Chemed Corp earned $19.89 per diluted share (EPS) in fiscal year 2024. This represents an increase of 10.9% from the prior year.
Chemed Corp held $178.3M in cash against $0 in long-term debt as of fiscal year 2024.
Chemed Corp paid $1.80 per share in dividends in fiscal year 2024. This represents an increase of 15.4% from the prior year.
Chemed Corp had 15M shares outstanding in fiscal year 2024. This represents a decrease of 3.2% from the prior year.
Chemed Corp's gross margin was 35.1% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.1 percentage points from the prior year.
Chemed Corp's operating margin was 15.1% in fiscal year 2024, reflecting core business profitability. This is up 0.0 percentage points from the prior year.
Chemed Corp's net profit margin was 12.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 0.4 percentage points from the prior year.
Chemed Corp's ROE was 27.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.
Chemed Corp spent $361.4M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 433.8% from the prior year.
Chemed Corp invested $49.5M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 12.9% from the prior year.
CHE Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $624.9M+1.0% | $618.8M-4.4% | $646.9M+1.1% | $640.0M+7.4% | $595.9M+1.1% | $589.2M+0.6% | $585.9M+3.8% | $564.5M |
| Cost of Revenue | $428.0M-1.4% | $434.1M+0.8% | $430.5M+6.1% | $405.9M+4.1% | $389.8M+1.2% | $385.1M+7.5% | $358.3M-1.1% | $362.4M |
| Gross Profit | $196.9M+6.6% | $184.7M-14.7% | $216.4M-7.6% | $234.1M+13.6% | $206.1M+1.0% | $204.1M-10.3% | $227.6M+12.6% | $202.2M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $105.8M+5.4% | $100.3M-5.0% | $105.6M+1.3% | $104.3M+2.0% | $102.3M-11.8% | $115.9M+15.4% | $100.4M+0.8% | $99.6M |
| Operating Income | $74.8M+9.8% | $68.1M-28.1% | $94.8M-16.8% | $113.9M+29.2% | $88.1M+21.8% | $72.3M-35.1% | $111.4M+28.3% | $86.8M |
| Interest Expense | $457K+3.2% | $443K+34.7% | $329K-34.1% | $499K+16.3% | $429K+0.9% | $425K+24.3% | $342K-23.0% | $444K |
| Income Tax | $19.3M+3.7% | $18.6M-22.1% | $23.9M-19.8% | $29.8M+29.9% | $22.9M+17.8% | $19.5M-23.8% | $25.5M+39.5% | $18.3M |
| Net Income | $64.2M+22.4% | $52.5M-26.8% | $71.8M-20.6% | $90.3M+27.4% | $70.9M+9.0% | $65.0M-27.8% | $90.1M+20.1% | $75.0M |
| EPS (Diluted) | $4.46+24.9% | $3.57-26.5% | $4.86-19.0% | $6.00+29.0% | $4.65+9.7% | $4.24-28.3% | $5.91+19.9% | $4.93 |
CHE Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.6B-5.5% | $1.7B-0.5% | $1.7B+3.5% | $1.7B-3.8% | $1.7B+0.4% | $1.7B+3.6% | $1.7B+6.8% | $1.6B |
| Current Assets | $395.2M-19.6% | $491.4M-2.2% | $502.4M+27.3% | $394.7M-15.0% | $464.6M-13.9% | $539.6M+7.7% | $500.8M+26.9% | $394.5M |
| Cash & Equivalents | $129.8M-48.1% | $249.9M+43.7% | $173.9M-2.5% | $178.3M-20.0% | $222.9M-28.9% | $313.4M+18.7% | $264.0M+52.4% | $173.2M |
| Inventory | $8.2M-9.9% | $9.1M+17.4% | $7.8M-4.9% | $8.2M-23.7% | $10.7M+0.2% | $10.7M-10.8% | $12.0M-4.1% | $12.5M |
| Accounts Receivable | $215.6M+16.6% | $184.9M-35.3% | $285.9M+67.0% | $171.2M-7.5% | $185.0M+4.3% | $177.3M-2.3% | $181.5M+8.0% | $168.0M |
| Goodwill | $667.0M0.0% | $667.0M0.0% | $666.9M0.0% | $666.7M+0.7% | $662.1M+11.9% | $591.5M+1.1% | $585.0M0.0% | $585.0M |
| Total Liabilities | $546.9M+5.3% | $519.4M-4.7% | $544.8M-0.9% | $549.6M+4.1% | $527.7M-3.0% | $544.1M-2.9% | $560.2M+3.2% | $542.8M |
| Current Liabilities | $292.0M+10.7% | $263.9M-9.2% | $290.6M+1.7% | $285.7M+9.1% | $261.8M-7.2% | $282.0M-9.6% | $312.1M+5.0% | $297.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.1B-10.2% | $1.2B+1.4% | $1.2B+5.6% | $1.1B-7.3% | $1.2B+2.0% | $1.2B+6.8% | $1.1B+8.7% | $1.0B |
| Retained Earnings | $2.9B+2.0% | $2.8B+1.6% | $2.8B+2.4% | $2.7B+5.9% | $2.6B+2.6% | $2.5B+2.4% | $2.4B+3.6% | $2.4B |
CHE Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $83.4M-39.8% | $138.6M+323.3% | $32.7M-80.1% | $164.9M+112.7% | $77.5M-8.3% | $84.5M-22.1% | $108.6M+275.3% | $28.9M |
| Capital Expenditures | $17.5M+10.7% | $15.8M+19.1% | $13.3M+4.1% | $12.8M-86.8% | $96.4M+692.8% | $12.2M+3.3% | $11.8M+1.1% | $11.7M |
| Free Cash Flow | $65.9M-46.3% | $122.8M+530.9% | $19.5M-87.2% | $152.2M+904.5% | -$18.9M-126.1% | $72.4M-25.2% | $96.8M+460.4% | $17.3M |
| Investing Cash Flow | -$14.2M+8.1% | -$15.5M-13.2% | -$13.7M-9.2% | -$12.5M+86.6% | -$93.5M-382.3% | -$19.4M-66.1% | -$11.7M+24.4% | -$15.4M |
| Financing Cash Flow | -$189.3M-301.9% | -$47.1M-100.1% | -$23.5M+88.9% | -$212.5M-185.3% | -$74.5M-372.2% | -$15.8M-159.2% | -$6.1M-2213.7% | -$263K |
| Dividends Paid | $8.7M+19.9% | $7.2M-1.5% | $7.3M-2.3% | $7.5M+23.8% | $6.1M+0.1% | $6.0M-0.1% | $6.1M+0.4% | $6.0M |
| Share Buybacks | $180.8M+320.9% | $42.9M+29.3% | $33.2M-84.1% | $209.3M+275.4% | $55.8M+45.0% | $38.5M-3.7% | $39.9M+178.4% | $14.3M |
CHE Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.5%+1.7pp | 29.8%-3.6pp | 33.5%-3.1pp | 36.6%+2.0pp | 34.6%-0.1pp | 34.6%-4.2pp | 38.8%+3.0pp | 35.8% |
| Operating Margin | 12.0%+1.0pp | 11.0%-3.6pp | 14.6%-3.1pp | 17.8%+3.0pp | 14.8%+2.5pp | 12.3%-6.7pp | 19.0%+3.6pp | 15.4% |
| Net Margin | 10.3%+1.8pp | 8.5%-2.6pp | 11.1%-3.0pp | 14.1%+2.2pp | 11.9%+0.9pp | 11.0%-4.3pp | 15.4%+2.1pp | 13.3% |
| Return on Equity | 6.0%+1.6pp | 4.4%-1.7pp | 6.1%-2.0pp | 8.1%+2.2pp | 5.9%+0.4pp | 5.5%-2.6pp | 8.1%+0.8pp | 7.3% |
| Return on Assets | 4.0%+0.9pp | 3.1%-1.1pp | 4.2%-1.3pp | 5.4%+1.3pp | 4.1%+0.3pp | 3.8%-1.6pp | 5.4%+0.6pp | 4.8% |
| Current Ratio | 1.35-0.5 | 1.86+0.1 | 1.73+0.3 | 1.38-0.4 | 1.77-0.1 | 1.91+0.3 | 1.60+0.3 | 1.33 |
| Debt-to-Equity | 0.51+0.1 | 0.43-0.0 | 0.46-0.0 | 0.49+0.1 | 0.44-0.0 | 0.46-0.0 | 0.51-0.0 | 0.53 |
| FCF Margin | 10.5%-9.3pp | 19.8%+16.8pp | 3.0%-20.8pp | 23.8%+26.9pp | -3.2%-15.4pp | 12.3%-4.2pp | 16.5%+13.5pp | 3.1% |
Similar Companies
Frequently Asked Questions
What is Chemed Corp's annual revenue?
Chemed Corp (CHE) reported $2.4B in total revenue for fiscal year 2024. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Chemed Corp's revenue growing?
Chemed Corp (CHE) revenue grew by 7.4% year-over-year, from $2.3B to $2.4B in fiscal year 2024.
Is Chemed Corp profitable?
Yes, Chemed Corp (CHE) reported a net income of $302.0M in fiscal year 2024, with a net profit margin of 12.4%.
What is Chemed Corp's earnings per share (EPS)?
Chemed Corp (CHE) reported diluted earnings per share of $19.89 for fiscal year 2024. This represents a 10.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Chemed Corp's EBITDA?
Chemed Corp (CHE) had EBITDA of $429.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Chemed Corp's gross margin?
Chemed Corp (CHE) had a gross margin of 35.1% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Chemed Corp's operating margin?
Chemed Corp (CHE) had an operating margin of 15.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Chemed Corp's net profit margin?
Chemed Corp (CHE) had a net profit margin of 12.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Chemed Corp pay dividends?
Yes, Chemed Corp (CHE) paid $1.80 per share in dividends during fiscal year 2024.
What is Chemed Corp's return on equity (ROE)?
Chemed Corp (CHE) has a return on equity of 27.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Chemed Corp's free cash flow?
Chemed Corp (CHE) generated $368.0M in free cash flow during fiscal year 2024. This represents a 34.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Chemed Corp's operating cash flow?
Chemed Corp (CHE) generated $417.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Chemed Corp's total assets?
Chemed Corp (CHE) had $1.7B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Chemed Corp's capital expenditures?
Chemed Corp (CHE) invested $49.5M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Does Chemed Corp buy back shares?
Yes, Chemed Corp (CHE) spent $361.4M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Chemed Corp have outstanding?
Chemed Corp (CHE) had 15M shares outstanding as of fiscal year 2024.
What is Chemed Corp's current ratio?
Chemed Corp (CHE) had a current ratio of 1.38 as of fiscal year 2024, which is considered adequate.
What is Chemed Corp's debt-to-equity ratio?
Chemed Corp (CHE) had a debt-to-equity ratio of 0.49 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Chemed Corp's return on assets (ROA)?
Chemed Corp (CHE) had a return on assets of 18.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Chemed Corp's Altman Z-Score?
Chemed Corp (CHE) has an Altman Z-Score of 11.83, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Chemed Corp's Piotroski F-Score?
Chemed Corp (CHE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Chemed Corp's earnings high quality?
Chemed Corp (CHE) has an earnings quality ratio of 1.38x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Chemed Corp cover its interest payments?
Chemed Corp (CHE) has an interest coverage ratio of 205.9x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Chemed Corp?
Chemed Corp (CHE) scores 71 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.